Diestro Jose Danilo B, Vesagas Theodor S, Teleg Rosalia A, Aguilar Jose A, Anlacan Joseph P, Jamora Roland Dominic G
Department of Neurosciences, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines.
Philippine Movement Disorder Surgery Center, Cardinal Santos Medical Center, San Juan City, Philippines.
World Neurosurg. 2018 Jul;115:e650-e658. doi: 10.1016/j.wneu.2018.04.125. Epub 2018 Apr 28.
Deep brain stimulation (DBS) is an established treatment modality for Parkinson disease (PD). The first DBS for PD in the Philippines was performed at the Philippine Movement Disorder Surgery Center in 2006. There are no Philippine data on DBS for PD. We aim to determine the motor improvement and reduction in medication dosage of all patients with PD who underwent DBS at the Philippine Movement Disorder Surgery Center.
This is a retrospective study of all patients with PD (n = 17) who underwent DBS from 2006 to 2016. The change in the Unified Parkinson's Disease Rating Scale (UPDRS) motor and levodopa equivalent dose were determined.
There was a statistically significant reduction in the UPDRS motor in all patients off medication at 3 months (48.2%; P = 0.004), 1 year (47.3%; P = 0.026), 2 years (48.4%; P = 0.021), and 3 years (66.0%; P = 0.032) after DBS and on medication at 3 months (43.3%; P = 0.023), 6 months (24.7%; P = 0.053), and 1 year (38.1%; P = 0.033). A significant reduction in the dosage of PD medications was also seen until the second year of follow-up (52.3%; P < 0.001). Adverse events included an attempted suicide and a device-related infection.
DBS for PD improves the UPDRS motor score in the off-medication and on-medication state, with the maximal benefit seen at 3 years after surgery and reduces PD medication dosage by half. Although the benefit from DBS is undeniable, the high cost of the procedure precludes more patients from benefitting from it. There is a need for government support to expand access to DBS.
脑深部电刺激术(DBS)是帕金森病(PD)的一种既定治疗方式。菲律宾首例PD的DBS手术于2006年在菲律宾运动障碍手术中心进行。目前尚无菲律宾关于PD的DBS数据。我们旨在确定在菲律宾运动障碍手术中心接受DBS治疗的所有PD患者的运动改善情况及药物剂量减少情况。
这是一项对2006年至2016年期间接受DBS治疗的所有PD患者(n = 17)的回顾性研究。测定统一帕金森病评定量表(UPDRS)运动评分及左旋多巴等效剂量的变化。
所有患者在DBS术后3个月(48.2%;P = 0.004)、1年(47.3%;P = 0.026)、2年(48.4%;P = 0.021)和3年(66.0%;P = 0.032)未服药时以及3个月(43.3%;P = 0.023)、6个月(24.7%;P = 0.053)和1年(38.1%;P = 0.033)服药时,UPDRS运动评分均有统计学显著降低。直到随访第二年,PD药物剂量也有显著减少(52.3%;P < 0.001)。不良事件包括1例自杀未遂和1例与设备相关的感染。
PD的DBS可改善未服药和服药状态下的UPDRS运动评分,术后3年获益最大,并使PD药物剂量减少一半。尽管DBS的益处不可否认,但该手术成本高昂,使更多患者无法从中受益。需要政府支持以扩大DBS的可及性。